China Tracker - Details for Huifeng Bio-Pharma (HFGB)


Warning: fopen(): php_network_getaddresses: getaddrinfo failed: Name or service not known in /home/fixyou/public_html/tracker_details.php on line 58

Warning: fopen(http://finance.yahoo.com/d/quotes.csv?s=HFGB&f=snl1a2xf6): failed to open stream: php_network_getaddresses: getaddrinfo failed: Name or service not known in /home/fixyou/public_html/tracker_details.php on line 58

Warning: fgetcsv() expects parameter 1 to be resource, boolean given in /home/fixyou/public_html/tracker_details.php on line 60

Warning: fclose() expects parameter 1 to be resource, boolean given in /home/fixyou/public_html/tracker_details.php on line 61
 Huifeng Bio-Pharma
 Basic Facts and History
Data Source: Annual Report for the period ended 2009-12-31
Reporting Type: U.S. Company (10-K Filings) 
Incorporation: Nevada 
Corporate Headquarters: China (Shaanxi) 
Going Public: Reverse Merger on 2004-12-20 
Previous Entity: Secured Data, Inc. 
Main Operating Subsidiary: Xi’an Huifeng Bio-Technic, Inc., founded 2000 
Investor Relations: Investor Relations Website 
Internal Controls: effective 
Internal Controls Audit: not performed 
Auditor Opinion:

The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. (Baker Tilly Hong Kong)

This company is overdue with their latest quarterly or annual report! The Trading China Rating is suspended until the company is back in compliance with SEC filing rules.

This company has reported corporate governance issues. You may want to look further into possible issues before making an investment decision.

 
 Ownership
Main Shareholder: Jing’an Wang (Chairman, CEO) 
Ownership: 31.69% 
 
 Auditor Trail (since January 1, 2009)
2011-08-09Patrizio & ZhaoAppointment
2011-04-15Baker Tilly Hong KongResignation
2010-02-17Baker Tilly Hong KongAppointment (Merger)
2010-02-17Jimmy C. H. Cheung & Co.Resignation (Merger)
2005-03-16Jimmy C. H. Cheung & Co.Appointment
 
 Senior Management Trail (since January 1, 2009)
2004-12-20Sanding TaoCFOAppointment
 
 Fiscal Year
Fiscal Year ends: December 31 
First Quarter 10-Q: due by 2019-05-15 
Second Quarter 10-Q: due by 2019-08-15 
Third Quarter 10-Q: due by 2018-11-15 
Annual Report 10-K: due by 2019-03-31 
HFGB
Healthcare & Drugs
SCORE
6
UNDER REVIEW
READ: Score Cards Explained
SAFETY/RISK SCORE
EXTREME RISK
DETAILS: Safety/Risk Model for HFGB
Current Price:  n/a
F10k Day (2005-04-04): -100.00%$0.81
2009 Close: -100.00%$0.93
2010 Close: -100.00%$0.68
2011 Close: -100.00%$0.04
High (2012-04-13): -100.00%$0.08
Low (2012-10-19): -100.00%$0.02
Exchange:
Market Capitalization: n/a
Total Shares: 26.55 mill
Float: n/a
Avg Volume: n/a
Last Quarter: 2010-09-30
Revenue (MRQ): 7.42 mill
Net Income (MRQ): 2.42 mill
Op. Cash Flow (MRQ): 1.29 mill
all financial data provided without warranty